A single jab that can protect a newborn child against respiratory syncytial virus for their first winter reduces the risk of illness by 75 per cent, new data show in a world-first breakthrough. RSV is responsible for roughly 29, 000 paediatric hospitalisations every year and about 80 child deaths, according to the Oxford Vaccine Group. There is currently no vaccination, treatment or preventative medicine and companies have spent decades searching for a way to combat the virus. Scientists at Astr